Wiki-CORONA

Search Results for: REEP6

20 interactions involving REEP6 - receptor accessory protein 6 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ADAT3 adenosine deaminase tRNA specific 3
  • tRNA modification in the nucleus and cytosol
COQ8A coenzyme Q8A
  • Coenzyme Q10 deficiency
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
FAM160A2 family with sequence similarity 160 member A2
HMBOX1 homeobox containing 1
IZUMO4 IZUMO family member 4
  • Acrosome Reaction and Sperm:Oocyte Membrane Binding
LITAF lipopolysaccharide induced TNF factor
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
LMNA lamin A/C
  • XBP1(S) activates chaperone genes
  • Signaling by BRAF and RAF fusions
  • Restrictive dermopathy
  • Emery-Dreifuss muscular dystrophy
  • Dilated cardiomyopathy (DCM)
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Mandibuloacral dysplasia
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
  • Limb-girdle muscular dystrophy (LGMD)
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Hutchinson-Gilford progeria syndrome
NDRG4 NDRG family member 4
PTPN9 protein tyrosine phosphatase non-receptor type 9
  • Interleukin-37 signaling
RPS20 ribosomal protein S20
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Peptide chain elongation
  • SRP-dependent cotranslational protein targeting to membrane
  • SRP-dependent cotranslational protein targeting to membrane
  • Viral mRNA Translation
  • Selenocysteine synthesis
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • Translation initiation complex formation
  • Formation of a pool of free 40S subunits
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Ribosomal scanning and start codon recognition
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Termination
  • Regulation of expression of SLITs and ROBOs
  • Response of EIF2AK4 (GCN2) to amino acid deficiency
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
SCAMP4 secretory carrier membrane protein 4
SDCBP syndecan binding protein
  • Ephrin signaling
  • Neurofascin interactions
  • Neutrophil degranulation
SNX1 sorting nexin 1
SNX15 sorting nexin 15
SPG21 SPG21 abhydrolase domain containing, maspardin
  • Hereditary spastic paraplegia (SPG)
TMEM259 transmembrane protein 259
TNS2 tensin 2
TXN2 thioredoxin 2
  • Degradation of cysteine and homocysteine
  • Detoxification of Reactive Oxygen Species
ZFYVE21 zinc finger FYVE-type containing 21
ZNF554 zinc finger protein 554
  • Generic Transcription Pathway